These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22531912)

  • 1. Loss of central and peripheral CD8+ T-cell tolerance to HFE in mouse models of human familial hemochromatosis.
    Boucherma R; Kridane-Miledi H; Vives FL; Vauchy C; Borg C; Kleinclauss F; Fiette L; Tiberghien P; Lemonnier FA; Rohrlich PS; Huetz F
    Eur J Immunol; 2012 Apr; 42(4):851-62. PubMed ID: 22531912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte gene expression signatures from patients and mouse models of hereditary hemochromatosis reveal a function of HFE as a negative regulator of CD8+ T-lymphocyte activation and differentiation in vivo.
    Costa M; Cruz E; Oliveira S; Benes V; Ivacevic T; Silva MJ; Vieira I; Dias F; Fonseca S; Gonçalves M; Lima M; Leitão C; Muckenthaler MU; Pinto J; Porto G
    PLoS One; 2015; 10(4):e0124246. PubMed ID: 25880808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The WT hemochromatosis protein HFE inhibits CD8⁺ T-lymphocyte activation.
    Reuben A; Phénix M; Santos MM; Lapointe R
    Eur J Immunol; 2014 Jun; 44(6):1604-14. PubMed ID: 24643698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function.
    Rohrlich PS; Fazilleau N; Ginhoux F; Firat H; Michel F; Cochet M; Laham N; Roth MP; Pascolo S; Nato F; Coppin H; Charneau P; Danos O; Acuto O; Ehrlich R; Kanellopoulos J; Lemonnier FA
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12855-60. PubMed ID: 16123136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HFE, the MHC and hemochromatosis: paradigm for an extended function for MHC class I.
    Cardoso CS; de Sousa M
    Tissue Antigens; 2003 Apr; 61(4):263-75. PubMed ID: 12753664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse HFE inhibits Tf-uptake and iron accumulation but induces non-transferrin bound iron (NTBI)-uptake in transformed mouse fibroblasts.
    Kielmanowicz MG; Laham N; Coligan JE; Lemonnier F; Ehrlich R
    J Cell Physiol; 2005 Jan; 202(1):105-14. PubMed ID: 15389541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of HFE in HepG2 cells reveals differences in intracellular distribution and co-localization of wt- and mutated forms.
    Pinto JP; Ramos P; de Sousa M
    Blood Cells Mol Dis; 2007; 39(1):75-81. PubMed ID: 17428702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis.
    Nicolas G; Viatte L; Lou DQ; Bennoun M; Beaumont C; Kahn A; Andrews NC; Vaulont S
    Nat Genet; 2003 May; 34(1):97-101. PubMed ID: 12704388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron-independent specific protein expression pattern in the liver of HFE-deficient mice.
    Petrak J; Myslivcova D; Halada P; Cmejla R; Cmejlova J; Vyoral D; Vulpe CD
    Int J Biochem Cell Biol; 2007; 39(5):1006-15. PubMed ID: 17376729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocyte-derived TNF and IFN-γ repress HFE expression in cancer cells.
    Reuben A; Godin-Ethier J; Santos MM; Lapointe R
    Mol Immunol; 2015 Jun; 65(2):259-66. PubMed ID: 25700349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell activation and thymic tolerance induction require different adhesion intensities of the CD8 co-receptor.
    Knobloch M; Schönrich G; Schenkel J; Malissen M; Malissen B; Schmitt-Verhulst AM; Hämmerling GJ; Arnold B
    Int Immunol; 1992 Oct; 4(10):1169-74. PubMed ID: 1489732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective role of calreticulin in HFE hemochromatosis.
    Pinto JP; Ramos P; de Almeida SF; Oliveira S; Breda L; Michalak M; Porto G; Rivella S; de Sousa M
    Free Radic Biol Med; 2008 Jan; 44(1):99-108. PubMed ID: 18045552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic hemochromatosis and the HFE gene: from molecular genetics to clinical diagnosis].
    Höhler T; Gerken G
    Z Gastroenterol; 2000 Jun; 38(6):509-15. PubMed ID: 10923364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HJV and HFE Play Distinct Roles in Regulating Hepcidin.
    Wu Q; Wang H; An P; Tao Y; Deng J; Zhang Z; Shen Y; Chen C; Min J; Wang F
    Antioxid Redox Signal; 2015 May; 22(15):1325-36. PubMed ID: 25608116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis.
    Muckenthaler M; Roy CN; Custodio AO; Miñana B; deGraaf J; Montross LK; Andrews NC; Hentze MW
    Nat Genet; 2003 May; 34(1):102-7. PubMed ID: 12704390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell receptor repertoire in hereditary hemochromatosis: a study of 32 hemochromatosis patients and 274 healthy subjects.
    Cardoso C; Porto G; Lacerda R; Resende D; Rodrigues P; Bravo F; Oliveira JC; Justiça B; de Sousa M
    Hum Immunol; 2001 May; 62(5):488-99. PubMed ID: 11334672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic study of variation in normal mouse iron homeostasis reveals ceruloplasmin as an HFE-hemochromatosis modifier gene.
    Gouya L; Muzeau F; Robreau AM; Letteron P; Couchi E; Lyoumi S; Deybach JC; Puy H; Fleming R; Demant P; Beaumont C; Grandchamp B
    Gastroenterology; 2007 Feb; 132(2):679-86. PubMed ID: 17258727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron in skin of mice with three etiologies of systemic iron overload.
    Adams BD; Lazova R; Andrews NC; Milstone LM
    J Invest Dermatol; 2005 Dec; 125(6):1200-5. PubMed ID: 16354190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemochromatosis protein HFE C282Y conformational considerations.
    Lawless MW
    Hepatology; 2010 Jul; 52(1):398-9. PubMed ID: 20232489
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis.
    Cooksey RC; Jouihan HA; Ajioka RS; Hazel MW; Jones DL; Kushner JP; McClain DA
    Endocrinology; 2004 Nov; 145(11):5305-12. PubMed ID: 15308612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.